Tata dipute: Lawyers Singhvi, Salve now on opposing sides

While Salve publicly defended Chandrasekaran’s reappointment and endorsed idea of listing Tata Sons, Singhvi accused Tata Sons of undermining shareholder rights MUMBAI: It is Singhvi versus Salve in the Tata battle. After standing together for Tata Sons and Tata Trusts in the Cyrus Mistry case, two of India’s most high-profile lawyers are now on opposite…

Read More

NSE IPO: Shareholders still retain significant stake despite tendering shares in offer-for-sale

Despite participating in the share sale, several of the larger institutional investors have made only limited reductions to their holdings. NSE IPO: Most existing shareholders of the National Stock Exchange of India (NSE) have continued to hold a substantial part of their stakes even after selling shares through the offer-for-sale (OFS) portion of the exchange’s…

Read More

Despite a 2025 advisory against cough syrups for very young children, prescribing continued; India now weighs a red warning on bottles saying they should not be used in children under 4

The bottle label could prominently carry a red warning. (Image for representative purpose only) The use of cough syrups for children under the age of four continues despite the drug regulator’s guidelines. Now, India’s drug regulator is examining a proposal to make changes to cough syrup labels to discourage their use in children under four…

Read More